Increase funding to Medicare so that more medical school graduates can enter residency in hospitals.
There has been an artificial cap on Medicare residency funding since 1997.
By increasing the supply of doctors in the marketplace, this will eventually lead to lower healthcare costs for all Americans.
From AI:
The American Medical Association (AMA) successfully lobbied Congress in 1997 to impose a cap on Medicare funding for graduate medical education (GME) residency slots, effectively freezing the number of federally supported positions at 1996 levels under the Balanced Budget Act. This policy limited the overall supply of new physicians entering the workforce, contributing to persistent doctor shortages that have driven up physician salaries by constraining supply relative to demand. Critics, including health policy analysts, have argued that the AMA’s advocacy was motivated at least in part by a desire to protect high physician incomes, as a restricted supply enhances doctors’ market leverage and bargaining power.At the time, the AMA justified the cap by warning of an impending “oversupply” of physicians, based on projections from a 1980 Graduate Medical Education National Advisory Committee report. However, these projections proved inaccurate, and the cap has since exacerbated shortages—forecasts now predict a U.S. physician shortfall of 37,800 to 124,000 by 2034. As a result, about 25% of U.S. physicians are now trained abroad to fill gaps in domestic residency slots.The AMA’s stance has since evolved; by 2019, it began advocating to lift the Medicare GME cap, and as recently as 2024, it supported bipartisan legislation like the Resident Physician Shortage Reduction Act to add 14,000 new slots. Despite this shift, the 1997 cap remains in place, and the AMA continues to face criticism for its historical role in creating the supply bottleneck.